The Growth Hormone market size is valued at USD 7.32 Bn in 2026.
The Growth Hormone market is projected to grow at a CAGR of 6% by 2033.
The Growth Hormone market growth is driven by rising prevalence of Turner syndrome and growth hormone deficiency, increasing awareness regarding early diagnosis and treatment, and growing R&D activities for advanced therapies.
North America is a dominating region for the Growth Hormone market.
Novo Nordisk A/S, Pfizer Inc., Eli Lilly and Company, Merck KGaA, and Novartis AG are some leading industry players in the Growth Hormone market.